These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7432527)

  • 1. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 3. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M; Totaro JA
    Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.
    Ross SB
    J Neurochem; 1991 Jan; 56(1):22-9. PubMed ID: 1824780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 3H-domperidone binding on striatal dopamine receptors.
    Martres MP; Baudry M; Schwartz JC
    Life Sci; 1978 Oct; 23(17-18):1781-4. PubMed ID: 723450
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
    Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
    Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic D-3 binding sites are not presynaptic autoreceptors.
    Leff SE; Creese I
    Nature; 1983 Dec 8-14; 306(5943):586-9. PubMed ID: 6417548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
    Arana GW; Lamont JS; Baldessarini RJ; Teicher MH; Neumeyer JL; Cohen BM
    Neuropharmacology; 1984 Aug; 23(8):885-92. PubMed ID: 6483116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-Domperidone: a selective ligand for dopamine receptors.
    Baudry M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):231-7. PubMed ID: 503250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.